303 related articles for article (PubMed ID: 16178789)
21. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
[TBL] [Abstract][Full Text] [Related]
22. Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor.
Campana G; Pasini P; Roda A; Spampinato S
Biochem Pharmacol; 2005 Jun; 69(12):1755-63. PubMed ID: 15935148
[TBL] [Abstract][Full Text] [Related]
23. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.
Landrier JF; Eloranta JJ; Vavricka SR; Kullak-Ublick GA
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G476-85. PubMed ID: 16269519
[TBL] [Abstract][Full Text] [Related]
24. The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farsenoid X receptor-mediated antagonism.
Deng R; Yang D; Radke A; Yang J; Yan B
J Pharmacol Exp Ther; 2007 Mar; 320(3):1153-62. PubMed ID: 17135343
[TBL] [Abstract][Full Text] [Related]
25. The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone.
Wang S; Lai K; Moy FJ; Bhat A; Hartman HB; Evans MJ
Endocrinology; 2006 Sep; 147(9):4025-33. PubMed ID: 16675527
[TBL] [Abstract][Full Text] [Related]
26. Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity.
Kitada H; Miyata M; Nakamura T; Tozawa A; Honma W; Shimada M; Nagata K; Sinal CJ; Guo GL; Gonzalez FJ; Yamazoe Y
J Biol Chem; 2003 May; 278(20):17838-44. PubMed ID: 12637555
[TBL] [Abstract][Full Text] [Related]
27. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.
Goodwin B; Jones SA; Price RR; Watson MA; McKee DD; Moore LB; Galardi C; Wilson JG; Lewis MC; Roth ME; Maloney PR; Willson TM; Kliewer SA
Mol Cell; 2000 Sep; 6(3):517-26. PubMed ID: 11030332
[TBL] [Abstract][Full Text] [Related]
28. The role of FXR in disorders of bile acid homeostasis.
Eloranta JJ; Kullak-Ublick GA
Physiology (Bethesda); 2008 Oct; 23():286-95. PubMed ID: 18927204
[TBL] [Abstract][Full Text] [Related]
29. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
[TBL] [Abstract][Full Text] [Related]
30. The amino acid residues asparagine 354 and isoleucine 372 of human farnesoid X receptor confer the receptor with high sensitivity to chenodeoxycholate.
Cui J; Heard TS; Yu J; Lo JL; Huang L; Li Y; Schaeffer JM; Wright SD
J Biol Chem; 2002 Jul; 277(29):25963-9. PubMed ID: 12004058
[TBL] [Abstract][Full Text] [Related]
31. Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding.
Kassam A; Miao B; Young PR; Mukherjee R
J Biol Chem; 2003 Mar; 278(12):10028-32. PubMed ID: 12519787
[TBL] [Abstract][Full Text] [Related]
32. Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated.
Xu G; Pan LX; Li H; Shang Q; Honda A; Shefer S; Bollineni J; Matsuzaki Y; Tint GS; Salen G
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G730-5. PubMed ID: 14684380
[TBL] [Abstract][Full Text] [Related]
33. FXR, a bile acid receptor and biological sensor.
Tu H; Okamoto AY; Shan B
Trends Cardiovasc Med; 2000 Jan; 10(1):30-5. PubMed ID: 11150726
[TBL] [Abstract][Full Text] [Related]
34. The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases.
Niesor EJ; Flach J; Lopes-Antoni I; Perez A; Bentzen CL
Curr Pharm Des; 2001 Mar; 7(4):231-59. PubMed ID: 11254888
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation.
Fujino T; Une M; Imanaka T; Inoue K; Nishimaki-Mogami T
J Lipid Res; 2004 Jan; 45(1):132-8. PubMed ID: 13130122
[TBL] [Abstract][Full Text] [Related]
36. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp.
Denson LA; Sturm E; Echevarria W; Zimmerman TL; Makishima M; Mangelsdorf DJ; Karpen SJ
Gastroenterology; 2001 Jul; 121(1):140-7. PubMed ID: 11438503
[TBL] [Abstract][Full Text] [Related]
37. Catabolites of cholesterol synthesis pathways and forskolin as activators of the farnesoid X-activated nuclear receptor.
Howard WR; Pospisil JA; Njolito E; Noonan DJ
Toxicol Appl Pharmacol; 2000 Mar; 163(2):195-202. PubMed ID: 10698678
[TBL] [Abstract][Full Text] [Related]
38. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
Jiao N; Baker SS; Chapa-Rodriguez A; Liu W; Nugent CA; Tsompana M; Mastrandrea L; Buck MJ; Baker RD; Genco RJ; Zhu R; Zhu L
Gut; 2018 Oct; 67(10):1881-1891. PubMed ID: 28774887
[TBL] [Abstract][Full Text] [Related]
39. The nuclear bile acid receptor FXR is activated by PGC-1alpha in a ligand-dependent manner.
Kanaya E; Shiraki T; Jingami H
Biochem J; 2004 Sep; 382(Pt 3):913-21. PubMed ID: 15202934
[TBL] [Abstract][Full Text] [Related]
40. Identification of a nuclear receptor for bile acids.
Makishima M; Okamoto AY; Repa JJ; Tu H; Learned RM; Luk A; Hull MV; Lustig KD; Mangelsdorf DJ; Shan B
Science; 1999 May; 284(5418):1362-5. PubMed ID: 10334992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
